DK1847258T4 - Partialglycerider som smøremiddel til farmaceutiske sammensætninger indeholdende thieno[3,2-c]pyridin-derivater - Google Patents

Partialglycerider som smøremiddel til farmaceutiske sammensætninger indeholdende thieno[3,2-c]pyridin-derivater

Info

Publication number
DK1847258T4
DK1847258T4 DK06007841.7T DK06007841T DK1847258T4 DK 1847258 T4 DK1847258 T4 DK 1847258T4 DK 06007841 T DK06007841 T DK 06007841T DK 1847258 T4 DK1847258 T4 DK 1847258T4
Authority
DK
Denmark
Prior art keywords
lubricant
pharmaceutical compositions
compositions containing
pyridine derivatives
partial glycerides
Prior art date
Application number
DK06007841.7T
Other languages
English (en)
Other versions
DK1847258T3 (da
Inventor
Thomas Dr Beckert
Michael Braun
Klaus Neuer
Original Assignee
Acino Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36968494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1847258(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acino Pharma Ag filed Critical Acino Pharma Ag
Publication of DK1847258T3 publication Critical patent/DK1847258T3/da
Application granted granted Critical
Publication of DK1847258T4 publication Critical patent/DK1847258T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
DK06007841.7T 2006-04-13 2006-04-13 Partialglycerider som smøremiddel til farmaceutiske sammensætninger indeholdende thieno[3,2-c]pyridin-derivater DK1847258T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06007841A EP1847258B2 (de) 2006-04-13 2006-04-13 Partialglyceride als Schmiermittel für pharmazeutische Zusammensetzungen enthaltend Thieno[3,2-c]pyridin-Derivate

Publications (2)

Publication Number Publication Date
DK1847258T3 DK1847258T3 (da) 2010-08-09
DK1847258T4 true DK1847258T4 (da) 2013-04-15

Family

ID=36968494

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06007841.7T DK1847258T4 (da) 2006-04-13 2006-04-13 Partialglycerider som smøremiddel til farmaceutiske sammensætninger indeholdende thieno[3,2-c]pyridin-derivater

Country Status (8)

Country Link
EP (1) EP1847258B2 (da)
AT (1) ATE464881T1 (da)
CY (1) CY1110215T1 (da)
DE (2) DE502006006787D1 (da)
DK (1) DK1847258T4 (da)
ES (1) ES2342965T5 (da)
PL (1) PL1847258T5 (da)
PT (1) PT1847258E (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2095815B1 (en) 2008-02-26 2011-10-26 Laboratorios Lesvi, S.L. Pharmaceutical formulations containing clopidogrel
KR101317809B1 (ko) 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN104644595B (zh) * 2015-03-09 2017-10-24 吕霄芳 一种含有氯吡格雷的固体药物组合物
CN105362243B (zh) * 2015-12-18 2018-12-11 重庆福安药业(集团)股份有限公司 硫酸氢氯吡格雷口服固体药物组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591592A (en) 1980-07-29 1986-05-27 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
US4908210A (en) * 1988-10-28 1990-03-13 Eastman Kodak Company Lactylic salt tablet formulations and tablets
CA2100836C (en) 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
US5872128A (en) * 1997-10-15 1999-02-16 Invamed, Inc. Stabilized composition of ticlopidine hydrochloride
WO2000001364A1 (en) 1998-07-01 2000-01-13 Sun Pharmaceutical Industries Ltd. Stable pharmaceutical compositions of thieno [3,2-c] pyridine derivatives
ES2149736T1 (es) * 1998-11-30 2000-11-16 Tecnimede Sociedade Tecnico Medicinal Sa Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
CA2363053C (en) 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
AU2002364212B2 (en) 2001-12-21 2007-09-20 Shire Laboratories Inc. Oral capsule formulation with increased physical stability
WO2004098593A1 (en) 2003-05-05 2004-11-18 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate composition
WO2004100932A1 (en) † 2003-05-14 2004-11-25 Eurand Pharmaceuticals Ltd. Controlled drug release composition resistant to in vivo mechanic stress
US20050095287A1 (en) * 2003-10-29 2005-05-05 Matharu Amol S. Fosinopril composition
GB0325603D0 (en) 2003-11-03 2003-12-10 Sandoz Ag Organic compounds
WO2005070464A2 (en) 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
IS2385B (is) † 2006-02-10 2008-07-15 Actavis Group Hf. Klópidógrel bísúlfat lyfjasamsetningar

Also Published As

Publication number Publication date
ES2342965T5 (es) 2013-04-03
PL1847258T3 (pl) 2010-09-30
PT1847258E (pt) 2010-06-22
ATE464881T1 (de) 2010-05-15
EP1847258B1 (de) 2010-04-21
ES2342965T3 (es) 2010-07-20
EP1847258B2 (de) 2013-01-16
DE202006020892U1 (de) 2010-10-21
EP1847258A1 (de) 2007-10-24
DK1847258T3 (da) 2010-08-09
PL1847258T5 (pl) 2013-06-28
CY1110215T1 (el) 2015-01-14
DE502006006787D1 (de) 2010-06-02

Similar Documents

Publication Publication Date Title
MA30765B1 (fr) Derives innovants du thiophene
WO2008063910A3 (en) Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
WO2006131737A3 (en) Method and composition for treating inflammatory disorders
CY1110215T1 (el) ΜΕΡΙΚΑ ΓΛΥΚΕΡΙΔΙΑ ΣΑΝ ΛΙΠΑΝΤΙΚΑ ΜΕΣΑ ΓΙΑ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΠΕΡΙΕΧΟΥΝ ΠΑΡΑΓΩΓΑ ΘΕΙΕΝΟ[3,2-c]ΠΥΡΙΔΙΝΗΣ
WO2007077560A3 (en) Cryoprotective compositions and methods of using same
NO345139B1 (no) Florizinanaloger som inhibitorer av glukosekotransportør 2 og farmasøytisk sammensetning derav
AR047928A1 (es) Derivados de tetrahidropiridoindol
CL2007002867A1 (es) Compuestos derivados de 2-(bencimidazolil)purina, inhibidores de janus quinasa 3; composicion farmaceutica que los contiene; y su uso para tratar enfermedades autoinmune, inflamatorias, cardiovasculares, rechazo de implante, entre otras.
DK1751108T3 (da) Adamantyl-acetamidderivater som inhibitorer for 11-beta-hydroxysteroid-dehydrogenase-type 1-enzymet
ECSP099387A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
CL2007002095A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composicion empacada; metodo para esterilizarla; util para cicatrizar tejido donde la dermis se ha desgarrado.
NO20075111L (no) Farmasoytisk sammensetning
WO2009074950A3 (en) Thiophene derivatives as agonists of s1p1/edg1
DK1776010T3 (da) Fremgangsmåde til fremstilling af vandige aktivstofsammensætninger af aktivstoffer, som er tungt oplöselige i vand
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
WO2008066899A3 (en) Nanoparticulate formulations and methods for the making and use thereof
WO2010041141A3 (en) Oil-based foamable carriers and formulations
WO2007124090A3 (en) Lyophilized therapeutic peptibody formulations
WO2009100441A3 (en) Depot formulations
BRPI0717699A2 (pt) "composição e seus processos de preparação, uso de uma composição e uso coméstico de uma composição!
WO2008039472A3 (en) Stabilizing compositions for antibiotics and methods of use
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
WO2008000731A3 (en) Pharmaceutical composition for the oral administration of omega polyenoic fatty acids
MX2009012782A (es) Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados.